Across these, severe reduction in presynaptic striatal dopamine transporter density in patients with ODS-induced parkinsonism was demonstrated, suggesting damage to the nigrostriatal pathway (159–162), The asymmetry of clinical signs correlated well with asymmetric reduction in uptake of the radiotracer ligand (159–161). The gene discussed is SLC6A3; the disease is Parkinsonism.